Previous close | 0.0002 |
Open | 0.0002 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0002 - 0.0002 |
52-week range | 0.0001 - 0.0098 |
Volume | |
Avg. volume | 5,843,113 |
Market cap | 1M |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ANEW MEDICAL, INC. (OTC: LEAS), an early-stage biotechnology company focused on developing disruptive new therapies to treat age-related neurodegenerative diseases, previously announced that it has entered into a definitive business combination agreement with Redwoods Acquisition Corp. (NASDAQ: RWOD; "Redwoods"), a publicly traded special purpose acquisition company, or SPAC. ANEW MEDICAL (ANEW) currently has its common stock quoted on the OTC Markets under the symbol "LEAS".